Worsening of steatosis is an independent factor of fibrosis progression in untreated patients with chronic hepatitis C and paired liver biopsies.
about
Hepatitis C virus differentially modulates activation of forkhead transcription factors and insulin-induced metabolic gene expressionThe accuracy of the report of hepatic steatosis on ultrasonography in patients infected with hepatitis C in a clinical setting: a retrospective observational studyNAFLD and NASH in HCV Infection: Prevalence and Significance in Hepatic and Extrahepatic ManifestationsHepatitis C Virus, Insulin Resistance, and SteatosisMetabolic factors and chronic hepatitis C: a complex interplayEffect of antiviral treatment on evolution of liver steatosis in patients with chronic hepatitis C: indirect evidence of a role of hepatitis C virus genotype 3 in steatosisInsulin resistance is a cause of steatosis and fibrosis progression in chronic hepatitis CSTEATOSIS IN CHRONIC HEPATITIS C: WHY DOES IT REALLY MATTER?The genotype 3-specific hepatitis C virus core protein residue phenylalanine 164 increases steatosis in an in vitro cellular modelSpecific Polymorphisms in Hepatitis C Virus Genotype 3 Core Protein Associated with Intracellular Lipid AccumulationDomain 3 of Hepatitis C Virus Core Protein Is Sufficient for Intracellular Lipid AccumulationHepatitis C Virus Proteins Induce Lipogenesis and Defective Triglyceride Secretion in Transgenic MiceLipid dysregulation in hepatitis C virus, and impact of statin therapy upon clinical outcomesMultiparametric magnetic resonance imaging predicts clinical outcomes in patients with chronic liver disease.Transient elastography: Kill two birds with one stone?Clinical features of hepatitis C virus carriers with persistently normal alanine aminotransferase levels.Evaluating progression of liver disease from repeat liver biopsies in children with chronic hepatitis C: a retrospective study.Mechanisms and significance of liver steatosis in hepatitis C virus infectionRelationship between the severity of hepatitis C virus-related liver disease and the presence of Helicobacter species in the liver: a prospective study.Systematic review: identifying patients with chronic hepatitis C in need of early treatment and intensive monitoring--predictors and predictive models of disease progressionPredicting the probable outcome of treatment in HCV patients.NAFLD Prevalence in a Young Cadaveric Organ Donor Population.Central portalization correlates with fibrosis but not with risk factors for nonalcoholic steatohepatitis in steatotic chronic hepatitis C.Viral and host causes of fatty liver in chronic hepatitis BWeight-related effects on disease progression in the hepatitis C antiviral long-term treatment against cirrhosis trialChanges in lipid metabolism in chronic hepatitis C.Management of chronic hepatitis C.Steatosis and fibrosis in patients with chronic hepatitis C.Hepatitis C virus core protein decreases lipid droplet turnover: a mechanism for core-induced steatosis.Excess body weight, liver steatosis, and early fibrosis progression due to hepatitis C recurrence after liver transplantationManagement of chronic hepatitis C virus infection: a new era of disease control.Hepatitis C: What is the nature of the problem?End-stage renal disease and African American race are independent predictors of mild liver fibrosis in patients with chronic hepatitis C infection.TNF-{alpha}, chronic hepatitis C and diabetes: a novel triad.Hepatitis C virus-induced hepatocellular steatosis.Ongoing liver inflammation in patients with chronic hepatitis C and sustained virological responseReview article: hepatitis C virus-associated steatosis--pathogenic mechanisms and clinical implications.Review article: an unexpected virus-host interaction--the hepatitis C virus-diabetes link.Chronic hepatitis C virus infection and post-liver transplantation diabetes mellitus.Hepatitis C and steatosis: a reappraisal.
P2860
Q24606745-8C5D0CBF-0089-4DBD-A914-9435A2340F66Q24794434-33C7417D-B3B3-4AB0-8031-3A953F683F42Q26745576-7134E607-E5B7-417C-8E88-F75D40290214Q26751755-B8883D56-A03C-4D6B-8CBE-5B7A4C7EADF6Q27011787-A80818FA-1423-4EB4-927D-8BD6E4642BC9Q27477968-21977D23-3142-4BB8-8DD4-52687BBFCF4AQ27477981-DE77C82D-055D-4D9F-9323-F49B6CF6B03EQ27478329-87FA10A9-5501-4FFA-9149-72BEA281B85CQ27485480-1EC2326E-9A7E-4D9D-9A23-AB8B75411468Q27486390-DA15209D-7342-41FF-96EA-954FB517A9C1Q27490435-C34248A2-0586-40C7-9728-743BD8EB85CCQ27490446-292360A3-1844-4A5B-BB18-4148B3D58875Q28081216-FF00FB7A-D9C8-417A-BE2F-8E6FFE7EED6BQ30389327-9A553987-F765-4D33-89C4-FA21538EBAC6Q30454363-703E2879-F141-40F2-86D6-3B8F76304B08Q30468484-419ABFB8-DBB8-4CA1-92DB-5DE5B6518C2DQ33862153-8AACCAD4-11BE-4170-983B-9114AA88A895Q33866272-AC38BCE8-20A8-42AE-B5BF-63EEB50B9C12Q33866459-A9331B4F-5C06-4DD2-AA12-03BD1B5478B4Q34207037-ECAEFFD0-C600-443B-95A4-B94C3355B176Q34409039-B4D2ED5A-ED89-4214-8098-B3AA6236B88CQ34546142-ABA8A11B-A4C2-491E-9B08-0D7D5C40B8BCQ34698082-3AC2AFD0-DA6E-42EC-9363-847C6E1A3587Q35010958-6EB075DD-F077-485A-80D5-A72130BFD69CQ35142681-A38EC171-D6E9-4DCE-9148-7E4335DC7E64Q35165949-CB9E461E-D7F3-452B-BBD8-B4729B28680BQ35522138-68738AA8-798D-41B9-BEFC-79DDE4A72E79Q35587506-B7275B02-B103-46D4-9D05-31E4FD50E1A8Q35604983-20A2B98A-3AB0-44EA-BDA3-FA43D0C1FE82Q35621603-64871BBE-DF69-460D-9722-EE14AC9A25D9Q35823410-7C26771E-4147-4708-9083-38380328AAF3Q35882845-D8EBC89D-444D-4DAE-B2BF-A0964ED3CDB4Q35893934-36E4E4C4-1ABF-4EFD-A465-726D18607C76Q35996414-E84B7891-3FDC-4883-926D-4D7D64D3EF1DQ36060022-CD0586BD-1A99-4424-B5A3-EB84291DD685Q36280109-72C8388B-6438-43A3-99A4-9FB2F790B34FQ36286318-529BA5CA-C08D-46AF-8FF5-A6F4753258EAQ36286323-60E0D393-09BC-4BD0-92C1-33A993FFBC2BQ36307547-2A113C93-A4FA-4E60-B388-708EA1EA36FFQ36377276-A326C21E-4E18-469B-82B0-BB546CC409E3
P2860
Worsening of steatosis is an independent factor of fibrosis progression in untreated patients with chronic hepatitis C and paired liver biopsies.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
Worsening of steatosis is an i ...... s C and paired liver biopsies.
@ast
Worsening of steatosis is an i ...... s C and paired liver biopsies.
@en
type
label
Worsening of steatosis is an i ...... s C and paired liver biopsies.
@ast
Worsening of steatosis is an i ...... s C and paired liver biopsies.
@en
prefLabel
Worsening of steatosis is an i ...... s C and paired liver biopsies.
@ast
Worsening of steatosis is an i ...... s C and paired liver biopsies.
@en
P2093
P2860
P356
P1433
P1476
Worsening of steatosis is an i ...... is C and paired liver biopsies
@en
P2093
D Dhumeaux
E-S Zafrani
F Roudot-Thoraval
P2860
P304
P356
10.1136/GUT.52.2.288
P407
P577
2003-02-01T00:00:00Z